vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and KNOT Offshore Partners LP (KNOP). Click either name above to swap in a different company.
KNOT Offshore Partners LP is the larger business by last-quarter revenue ($87.1M vs $47.7M, roughly 1.8× IRONWOOD PHARMACEUTICALS INC). KNOT Offshore Partners LP runs the higher net margin — 7.8% vs -4.8%, a 12.6% gap on every dollar of revenue. On growth, KNOT Offshore Partners LP posted the faster year-over-year revenue change (17.0% vs -47.3%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
KNOT Offshore Partners LP is a publicly traded master limited partnership focused on owning, operating and chartering purpose-built shuttle tankers. It serves offshore oil and gas production operators across key markets including the North Sea, Brazil and West Africa, supporting marine logistics for offshore energy extraction.
IRWD vs KNOP — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $87.1M |
| Net Profit | $-2.3M | $6.8M |
| Gross Margin | — | — |
| Operating Margin | 14.3% | 25.5% |
| Net Margin | -4.8% | 7.8% |
| Revenue YoY | -47.3% | 17.0% |
| Net Profit YoY | -200.9% | 153.0% |
| EPS (diluted) | $0.01 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.7M | — | ||
| Q3 25 | $122.1M | — | ||
| Q2 25 | $85.2M | $87.1M | ||
| Q1 25 | $41.1M | — | ||
| Q4 24 | $90.5M | — | ||
| Q3 24 | $91.6M | — | ||
| Q2 24 | $94.4M | $74.4M | ||
| Q1 24 | $74.9M | — |
| Q4 25 | $-2.3M | — | ||
| Q3 25 | $40.1M | — | ||
| Q2 25 | $23.6M | $6.8M | ||
| Q1 25 | $-37.4M | — | ||
| Q4 24 | $2.3M | — | ||
| Q3 24 | $3.6M | — | ||
| Q2 24 | $-860.0K | $-12.9M | ||
| Q1 24 | $-4.2M | — |
| Q4 25 | 14.3% | — | ||
| Q3 25 | 61.8% | — | ||
| Q2 25 | 53.2% | 25.5% | ||
| Q1 25 | -70.7% | — | ||
| Q4 24 | 34.8% | — | ||
| Q3 24 | 28.0% | — | ||
| Q2 24 | 26.5% | 1.8% | ||
| Q1 24 | 14.7% | — |
| Q4 25 | -4.8% | — | ||
| Q3 25 | 32.8% | — | ||
| Q2 25 | 27.7% | 7.8% | ||
| Q1 25 | -90.9% | — | ||
| Q4 24 | 2.5% | — | ||
| Q3 24 | 4.0% | — | ||
| Q2 24 | -0.9% | -17.3% | ||
| Q1 24 | -5.6% | — |
| Q4 25 | $0.01 | — | ||
| Q3 25 | $0.23 | — | ||
| Q2 25 | $0.14 | — | ||
| Q1 25 | $-0.23 | — | ||
| Q4 24 | $0.03 | — | ||
| Q3 24 | $0.02 | — | ||
| Q2 24 | $-0.01 | — | ||
| Q1 24 | $-0.03 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | $66.3M |
| Total DebtLower is stronger | — | $914.5M |
| Stockholders' EquityBook value | $-261.8M | — |
| Total Assets | $396.9M | $1.6B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $215.5M | — | ||
| Q3 25 | $140.4M | — | ||
| Q2 25 | $92.9M | $66.3M | ||
| Q1 25 | $108.5M | — | ||
| Q4 24 | $88.6M | — | ||
| Q3 24 | $88.2M | — | ||
| Q2 24 | $105.5M | $56.6M | ||
| Q1 24 | $121.5M | — |
| Q4 25 | — | — | ||
| Q3 25 | $199.5M | — | ||
| Q2 25 | $199.3M | $914.5M | ||
| Q1 25 | $199.2M | — | ||
| Q4 24 | $199.0M | — | ||
| Q3 24 | $198.8M | — | ||
| Q2 24 | $198.6M | $895.4M | ||
| Q1 24 | $398.3M | — |
| Q4 25 | $-261.8M | — | ||
| Q3 25 | $-264.2M | — | ||
| Q2 25 | $-308.2M | — | ||
| Q1 25 | $-334.1M | — | ||
| Q4 24 | $-301.3M | — | ||
| Q3 24 | $-311.3M | — | ||
| Q2 24 | $-321.7M | — | ||
| Q1 24 | $-330.5M | — |
| Q4 25 | $396.9M | — | ||
| Q3 25 | $396.1M | — | ||
| Q2 25 | $342.9M | $1.6B | ||
| Q1 25 | $327.2M | — | ||
| Q4 24 | $350.9M | — | ||
| Q3 24 | $389.5M | — | ||
| Q2 24 | $395.6M | $1.5B | ||
| Q1 24 | $438.8M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | — |
| Free Cash FlowOCF − Capex | $74.6M | — |
| FCF MarginFCF / Revenue | 156.3% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | — | ||
| Q3 25 | $47.6M | — | ||
| Q2 25 | $-15.1M | — | ||
| Q1 25 | $20.0M | — | ||
| Q4 24 | $15.2M | — | ||
| Q3 24 | $9.9M | — | ||
| Q2 24 | $33.5M | — | ||
| Q1 24 | $45.0M | — |
| Q4 25 | $74.6M | — | ||
| Q3 25 | $47.6M | — | ||
| Q2 25 | $-15.1M | — | ||
| Q1 25 | $19.9M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $9.9M | — | ||
| Q2 24 | $33.4M | — | ||
| Q1 24 | $44.9M | — |
| Q4 25 | 156.3% | — | ||
| Q3 25 | 39.0% | — | ||
| Q2 25 | -17.7% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 10.8% | — | ||
| Q2 24 | 35.4% | — | ||
| Q1 24 | 60.0% | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | — |
| Q4 25 | — | — | ||
| Q3 25 | 1.19× | — | ||
| Q2 25 | -0.64× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 6.74× | — | ||
| Q3 24 | 2.71× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
